CPH creso pharma limited

It's about the cash burn rate and the new revenue streams. If a...

  1. 3,926 Posts.
    lightbulb Created with Sketch. 764
    It's about the cash burn rate and the new revenue streams. If a substantial revenue stream eventuates, probably the market will sit up and take notice. If not............

    The anibidiol launch looks to be slightly delayed- this is where the first substantial revenue stream looks set to come from. An announcement on this would ignite the engines, one would think.

    People are waking up to the benefits of MC. Big future.

    -------------------------------------------------------------------------------------------------------------
    This post is based on my own research and is not investment advice. When making investment decisions, always DYOR.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.